GWAS1194442_H |
GCST90012109 |
Sex hormone-binding globulin levels |
180,726 European ancestry men |
G |
0.884644 |
1E-15 |
15 |
rs9379084 |
0.0153264 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:32042192 |
GWAS1119135_H |
GCST004988 |
Breast cancer |
76,192 European ancestry cases, 63,082 European ancestry controls |
A |
0.1206 |
0.000003 |
5.523 |
rs9379084 |
0.0486 |
breast carcinoma (EFO:0000305)
|
PMID:29059683 |
GWAS1638175_H |
GCST90492734 |
Type 2 diabetes |
50,251 African American cases, 103,909 African American controls, 88,109 East Asian ancestry cases, 339,395 East Asian ancestry controls, 242,283 European ancestry cases, 1,569,734 European ancestry controls, 29,375 Hispanic cases, 59,368 Hispanic controls, 1,602 South African ancestry cases, 976 South African ancestry controls, 16,832 South Asian ancestry cases, 33,767 South Asian ancestry controls |
G |
0.87617 |
7E-56 |
55.155 |
rs9379084 |
N/A |
|
PMID:38374256 |
GWAS1645697_H |
GCST90479626 |
Glucose (fasting status unknown, mean, inv-norm transformed) |
118,233 African American or Afro-Caribbean individuals, 57,284 Hispanic or Latin American individuals, 6,317 East Asian ancestry individuals, 419,946 European ancestry individuals |
G |
0.8905 |
1E-19 |
19 |
rs9379084 |
0.04461 |
glucose measurement (EFO:0004468)
|
PMID:39024449 |
GWAS1129678_H |
GCST006979 |
Heel bone mineral density |
426,824 British ancestry individuals |
G |
0.895148 |
1E-30 |
30 |
rs9379084 |
0.0340199 |
heel bone mineral density (EFO:0009270)
|
PMID:30598549 |
GWAS1708715_H |
GCST008163 |
Height |
1,249 whole genome sequenced European ancestry individuals, 3,541 whole genome sequenced individuals, 46,910 European ancestry individuals, 471 Carlantino (founder/genetic isolate) individuals, 1,197 Friuli Venezia Giulia (founder/genetic isolate) individuals, 1,043 Mylopotamos (founder/genetic isolate) individuals, 933 Pomak (founder/genetic isolate) individuals, 1,785 Val Borbera (founder/genetic isolate) individuals |
A |
0.1228 |
1E-7 |
7 |
rs9379084 |
0.0569 |
body height (OBA:VT0001253)
|
PMID:28552196 |
GWAS1132453_H |
GCST009379 |
Type 2 diabetes |
74,124 European ancestry cases, 824,006 European ancestry controls |
G |
0.8873 |
3E-21 |
20.523 |
rs9379084 |
1.11 |
|
PMID:30297969 |
GWAS586392_H |
GCST007066 |
Heel bone mineral density |
approximately 446,000 European ancestry individuals |
? |
NR |
8E-36 |
35.097 |
rs9379084 |
N/A |
heel bone mineral density (EFO:0009270)
|
PMID:30595370 |
GWAS1154042_H |
GCST007077 |
Type 2 diabetes |
approximately 459,000 European ancestry individuals |
? |
NR |
2E-15 |
14.699 |
rs9379084 |
N/A |
|
PMID:30595370 |
GWAS1715114_H |
GCST007841 |
Height |
approximately 458,000 European ancestry individuals |
? |
NR |
4E-65 |
64.398 |
rs9379084 |
N/A |
body height (OBA:VT0001253)
|
PMID:30595370 |
GWAS1655605_H |
GCST90479502 |
Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) |
98,578 African American or Afro-Caribbean individuals, 49,152 Hispanic or Latin American individuals, 5,466 East Asian ancestry individuals, 338,640 European ancestry individuals |
G |
0.8915 |
6E-14 |
13.222 |
rs9379084 |
0.0409 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1655765_H |
GCST90479501 |
Hemoglobin A1c (HbA1c, mean, inv-norm transformed) |
98,735 African American or Afro-Caribbean individuals, 49,225 Hispanic or Latin American individuals, 5,475 East Asian ancestry individuals, 338,848 European ancestry individuals |
G |
0.8916 |
1E-14 |
14 |
rs9379084 |
0.04331 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1655958_H |
GCST90479500 |
Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) |
98,772 African American or Afro-Caribbean individuals, 49,229 Hispanic or Latin American individuals, 5,477 East Asian ancestry individuals, 338,857 European ancestry individuals |
G |
0.8916 |
2E-14 |
13.699 |
rs9379084 |
0.04196 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1171764_H |
GCST006288 |
Heel bone mineral density |
76,067 European ancestry women, 66,420 European ancestry men |
G |
0.882997 |
3E-15 |
14.523 |
rs9379084 |
0.0413825 |
heel bone mineral density (EFO:0009270)
|
PMID:28869591 |
GWAS1172071_H |
GCST006288 |
Heel bone mineral density |
76,067 European ancestry women, 66,420 European ancestry men |
G |
0.883136 |
6E-9 |
8.222 |
rs9379084 |
0.0410614 |
heel bone mineral density (EFO:0009270)
|
PMID:28869591 |
GWAS1172225_H |
GCST006288 |
Heel bone mineral density |
76,067 European ancestry women, 66,420 European ancestry men |
G |
0.882837 |
4E-7 |
6.398 |
rs9379084 |
0.0397905 |
heel bone mineral density (EFO:0009270)
|
PMID:28869591 |
GWAS1178741_H |
GCST010118 |
Type 2 diabetes |
77,418 East Asian cases, 356,122 East Asian controls |
G |
0.799 |
2E-14 |
13.699 |
rs9379084 |
1.07 |
|
PMID:32499647 |
GWAS1181203_H |
GCST010557 |
Type 2 diabetes |
148,726 European ancestry cases, 24,646 African American cases, 8,616 Hispanic cases, 46,511 Asian ancestry cases, 965,732 European ancestry controls, 31,446 African American controls, 11,829 Hispanic controls, 169,776 Asian ancestry controls |
G |
0.843 |
5E-31 |
30.302 |
rs9379084 |
0.0715 |
|
PMID:32541925 |
GWAS1183419_H |
GCST010555 |
Type 2 diabetes |
148,726 European ancestry cases, 965,732 European ancestry controls |
G |
0.8803 |
4E-22 |
21.398 |
rs9379084 |
0.0747 |
|
PMID:32541925 |
GWAS1724978_H |
GCST008839 |
Height |
159,095 Japanese ancestry individuals |
? |
NR |
8E-30 |
29.097 |
rs9379084 |
0.03771175 |
body height (OBA:VT0001253)
|
PMID:31562340 |
GWAS1663022_H |
GCST90475097 |
Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) |
338,640 European ancestry individuals |
G |
0.8675 |
3E-22 |
21.523 |
rs9379084 |
0.04346 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1663763_H |
GCST90475094 |
Hemoglobin A1c (HbA1c, mean, inv-norm transformed) |
338,848 European ancestry individuals |
G |
0.8675 |
1E-24 |
24 |
rs9379084 |
0.04628 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1191835_H |
GCST90012110 |
Sex hormone-binding globulin levels adjusted for BMI |
368,929 European ancestry individuals |
G |
0.884415 |
5E-26 |
25.302 |
rs9379084 |
0.0138383 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:32042192 |
GWAS1192812_H |
GCST90012107 |
Sex hormone-binding globulin levels |
189,473 European ancestry women |
G |
0.884204 |
3E-10 |
9.523 |
rs9379084 |
0.0148429 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:32042192 |
GWAS1192862_H |
GCST90012111 |
Sex hormone-binding globulin levels |
370,125 European ancestry individuals |
G |
0.884415 |
5E-23 |
22.302 |
rs9379084 |
0.0145332 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:32042192 |
GWAS1192980_H |
GCST90012108 |
Sex hormone-binding globulin levels adjusted for BMI |
180,094 European ancestry men |
G |
0.884644 |
2E-20 |
19.699 |
rs9379084 |
0.0161934 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:32042192 |
GWAS1665255_H |
GCST90475091 |
Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) |
338,857 European ancestry individuals |
G |
0.8675 |
4E-23 |
22.398 |
rs9379084 |
0.0439 |
HbA1c measurement (EFO:0004541)
|
PMID:39024449 |
GWAS1201889_H |
GCST90012102 |
Bioavailable testosterone levels |
188,507 European ancestry women |
A |
0.11583500000000002 |
3E-8 |
7.523 |
rs9379084 |
0.0224985 |
testosterone measurement (EFO:0004908)
|
PMID:32042192 |
GWAS1201911_H |
GCST90012106 |
Sex hormone-binding globulin levels adjusted for BMI |
188,908 European ancestry women |
G |
0.884204 |
2E-10 |
9.699 |
rs9379084 |
0.012719 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:32042192 |
None Available |
GCST007923 |
Medication use (drugs used in diabetes) |
15,272 European ancestry cases, 29,0641 European ancestry controls |
A |
0.104171 |
3E-8 |
7.523 |
rs9379084 |
0.10827128 |
Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:31015401 |
GWAS1238137_H |
GCST90244004 |
Hemoglobin A1c levels |
288,127 East Asian ancestry individuals |
A |
0.1622 |
5E-11 |
10.302 |
rs9379084 |
0.04 |
HbA1c measurement (EFO:0004541)
|
PMID:36333282 |
GWAS1238189_H |
GCST90250911 |
Medication use for T2D (number of purchases) |
567,671 European ancestry individuals |
? |
NR |
3E-16 |
15.523 |
rs9379084 |
0.012871 |
Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:36653479 |
GWAS1242712_H |
GCST90267278 |
Diabetes (standard GWA) |
283,227 European ancestry individuals |
A |
NR |
2E-9 |
8.699 |
rs9379084 |
0.0057185 |
diabetes mellitus (EFO:0000400)
|
PMID:37106081 |
GWAS1252867_H |
GCST90104273 |
Sex hormone-binding globulin levels |
196,901 European ancestry individuals |
A |
0.113636 |
0.000004 |
5.398 |
rs9379084 |
0.0235686 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:35192695 |
GWAS1253235_H |
GCST90104297 |
Sex hormone-binding globulin levels |
4,522 African ancestry individuals, 196,901 European ancestry individuals |
? |
NR |
0.000007 |
5.155 |
rs9379084 |
4.502 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:35192695 |
GWAS1257036_H |
GCST90018756 |
Serum total protein levels |
133,321 East Asian ancestry individuals |
A |
0.274246 |
1E-11 |
11 |
rs9379084 |
0.0300352 |
total blood protein measurement (EFO:0004536)
|
PMID:34594039 |
GWAS1260722_H |
GCST90018926 |
Type 2 diabetes |
38,841 European ancestry cases, 451,248 European ancestry controls, 45,383 East Asian ancestry cases, 132,032 East Asian ancestry controls |
A |
NR |
1E-21 |
21 |
rs9379084 |
0.0816 |
|
PMID:34594039 |
GWAS1265522_H |
GCST90018706 |
Type 2 diabetes |
45,383 East Asian ancestry cases, 132,032 East Asian ancestry controls |
A |
0.275713508 |
1E-10 |
10 |
rs9379084 |
0.070026994 |
|
PMID:34594039 |
GWAS1274253_H |
GCST90274732 |
Cancer (pleiotropy) |
122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls |
A |
NR |
9E-9 |
8.046 |
rs9379084 |
N/A |
|
PMID:36929942 |
GWAS1285737_H |
GCST90239823 |
Free androgen index |
162,068 British ancestry men |
? |
NR |
4E-8 |
7.398 |
rs9379084 |
0.0298344 |
free androgen index (EFO:0007005)
|
PMID:36653534 |
GWAS1286590_H |
GCST90239821 |
Sex hormone-binding globulin levels |
163,363 British ancestry men |
? |
NR |
1E-18 |
18 |
rs9379084 |
0.0451938 |
sex hormone-binding globulin measurement (EFO:0004696)
|
PMID:36653534 |
GWAS1299364_H |
GCST007517 |
Type 2 diabetes |
up to 48,286 European ancestry cases, up to 250,671 European ancestry controls |
G |
0.887 |
2E-12 |
11.699 |
rs9379084 |
1.1 |
|
PMID:29632382 |
GWAS1299583_H |
GCST007518 |
Type 2 diabetes (adjusted for BMI) |
up to 48,286 European ancestry cases, up to 250,671 European ancestry controls |
G |
0.887 |
2E-13 |
12.699 |
rs9379084 |
1.09 |
|
PMID:29632382 |
GWAS1300124_H |
GCST007516 |
Type 2 diabetes (adjusted for BMI) |
48,286 European ancestry cases, 250,671 European ancestry controls, 33,126 African American, East Asian, Hispanic/Latino or South Asian cases, 120,161 African American, East Asian, Hispanic/Latino or South Asian controls |
G |
0.884 |
2E-17 |
16.699 |
rs9379084 |
1.1 |
|
PMID:29632382 |
GWAS1301247_H |
GCST007515 |
Type 2 diabetes |
48,286 European ancestry cases, 250,671 European ancestry controls, 33,126 African American, East Asian, Hispanic/Latino or South Asian cases, 120,161 African American, East Asian, Hispanic/Latino or South Asian controls |
G |
0.884 |
1E-13 |
13 |
rs9379084 |
1.08 |
|
PMID:29632382 |
GWAS1684223_H |
GCST008362 |
Birth weight |
298,142 European ancestry individuals, 6,635 African American individuals, 1,449 Filipino individuals, 420 Turkish individuals, 365 Moroccan individuals, 395 Surinamese individuals, 1,052 Afro-Caribbean individuals, 612 Hispanic individuals, 1,180 Thai individuals, 840 Chinese ancestry individuals, 10,133 individuals |
G |
0.882647 |
1E-7 |
7 |
rs9379084 |
0.021801 |
birth weight (EFO:0004344)
|
PMID:31043758 |
GWAS1305440_H |
GCST008363 |
Offspring birth weight |
210,267 European ancestry individuals, 19,802 individuals |
G |
0.883436 |
1E-16 |
16 |
rs9379084 |
0.040696 |
birth weight (EFO:0004344) parental genotype effect measurement (EFO:0005939)
|
PMID:31043758 |
GWAS1753198_H |
GCST90435412 |
Height |
404,900 European ancestry individuals |
? |
NR |
8E-55 |
54.097 |
rs9379084 |
0.0430333 |
body height (OBA:VT0001253)
|
PMID:39134668 |
None Available |
GCST90000025 |
Appendicular lean mass |
450,243 European ancestry individuals |
A |
0.1155 |
2E-20 |
19.699 |
rs9379084 |
0.0271 |
appendicular lean mass (EFO:0004980)
|
PMID:33097823 |
GWAS1325651_H |
GCST006433 |
Heel bone mineral density |
394,929 European ancestry individuals |
? |
NR |
5E-36 |
35.302 |
rs9379084 |
0.0389254 |
heel bone mineral density (EFO:0009270)
|
PMID:30048462 |
GWAS1329491_H |
GCST90000027 |
Appendicular lean mass |
244,730 European ancestry women |
A |
0.116 |
4E-9 |
8.398 |
rs9379084 |
0.02 |
appendicular lean mass (EFO:0004980)
|
PMID:33097823 |
GWAS1329739_H |
GCST90000026 |
Appendicular lean mass |
205,513 European ancestry men |
A |
0.116 |
3E-13 |
12.523 |
rs9379084 |
0.03 |
appendicular lean mass (EFO:0004980)
|
PMID:33097823 |
GWAS1693112_H |
GCST90132183 |
Type 2 diabetes |
251,740 European ancestry individuals, 139,705 East Asian ancestry individuals, 40,737 South Asian ancestry individuals, 27,417 Hispanic individuals, 30,167 African American individuals, 2,426 Zulu ancestry individuals |
G |
NR |
1E-26 |
26 |
rs9379084 |
1.09 |
|
PMID:35551307 |
GWAS1364964_H |
GCST90132184 |
Type 2 diabetes |
251,740 European ancestry individuals |
G |
0.888 |
4E-26 |
25.398 |
rs9379084 |
0.11 |
|
PMID:35551307 |
GWAS1365681_H |
GCST012227 |
Hip circumference adjusted for BMI |
186,825 British ancestry men |
A |
NR |
5E-10 |
9.302 |
rs9379084 |
0.0307534 |
BMI-adjusted hip circumference (EFO:0008039)
|
PMID:34021172 |
GWAS1366846_H |
GCST90132185 |
Type 2 diabetes |
139,705 East Asian ancestry individuals |
G |
0.822 |
1E-8 |
8 |
rs9379084 |
0.069 |
|
PMID:35551307 |
GWAS1383790_H |
GCST90018954 |
Gamma glutamyl transpeptidase |
344,104 European ancestry individuals, 133,471 East Asian ancestry individuals |
A |
NR |
7E-18 |
17.155 |
rs9379084 |
0.0232 |
serum gamma-glutamyl transferase measurement (EFO:0004532)
|
PMID:34594039 |
None Available |
GCST90309355 |
Body size (confirmatory factor analysis Factor 21) |
329,172 European ancestry individuals |
? |
NR |
1E-26 |
26 |
rs9379084 |
N/A |
size (EFO:0001695)
|
PMID:38965376 |
GWAS1388623_H |
GCST90309345 |
Respiratory disease (confirmatory factor analysis Factor 11) |
360,406 European ancestry individuals |
? |
NR |
9E-11 |
10.046 |
rs9379084 |
N/A |
respiratory system disease (EFO:0000684)
|
PMID:38965376 |
GWAS1394989_H |
GCST90444202 |
Type 2 diabetes |
51,256 African, African American, East Asian, South Asian, European, Middle Eastern, admixed American, other or other admixed ancestry cases, 370,487 African, African American, East Asian, South Asian, European, Middle Eastern, admixed American, other or other admixed ancestry controls |
G |
0.882868 |
4E-25 |
24.398 |
rs9379084 |
0.13 |
|
PMID:39379762 |
GWAS1401056_H |
GCST90018976 |
Serum total protein levels |
314,921 European ancestry individuals, 133,321 East Asian ancestry individuals |
A |
NR |
1E-14 |
14 |
rs9379084 |
0.023 |
total blood protein measurement (EFO:0004536)
|
PMID:34594039 |
None Available |
GCST90018981 |
Medication use (drugs used in diabetes) |
15,272 European ancestry cases, 290,641 European ancestry controls, 30,515 East Asian ancestry cases, 148,211 East Asian ancestry controls |
A |
NR |
1E-13 |
13 |
rs9379084 |
0.0744 |
Drugs used in diabetes use measurement (EFO:0009924)
|
PMID:34594039 |
None Available |
GCST90245995 |
Body surface area |
337,198 British ancestry individuals |
? |
NR |
2E-10 |
9.699 |
rs9379084 |
0.00431973 |
body surface area (EFO:0022196)
|
PMID:36502284 |
None Available |
GCST90129505 |
Colorectal cancer |
21,731 European ancestry cases, 47,444 European ancestry controls, 78,473 East Asian ancestry cases, 107,143 East Asian ancestry controls |
A |
NR |
2E-12 |
11.699 |
rs9379084 |
0.06967 |
|
PMID:36539618 |
GWAS1439854_H |
GCST90271558 |
Random glucose levels |
7,644 African ancestry individuals, 1,503 Chinese ancestry individuals, 7,407 Indian, Pakistani ancestry individuals, 458,862 European ancestry individuals |
A |
0.1163 |
1E-12 |
12 |
rs9379084 |
0.003536712 |
glucose measurement (EFO:0004468)
|
PMID:37679419 |
None Available |
GCST90271557 |
Random glucose levels |
458,862 European ancestry individuals |
A |
0.12 |
2E-12 |
11.699 |
rs9379084 |
0.0035 |
glucose measurement (EFO:0004468)
|
PMID:37679419 |
None Available |
GCST90428120 |
Whole body fat free mass (UKB data field 23101) |
337,739 European ancestry individuals |
A |
NR |
3E-10 |
9.523 |
rs9379084 |
0.0134137 |
lean body mass (EFO:0004995)
|
PMID:38538606 |
None Available |
GCST90244003 |
Fasting plasma glucose |
288,127 East Asian ancestry individuals |
A |
0.1622 |
3E-10 |
9.523 |
rs9379084 |
0.0261 |
obsolete_fasting blood glucose measurement (EFO:0004465)
|
PMID:36333282 |
None Available |
GCST90018739 |
Height |
165,056 East Asian ancestry individuals |
A |
0.272791 |
1E-26 |
26 |
rs9379084 |
0.0253576 |
body height (OBA:VT0001253)
|
PMID:34594039 |